Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer (Q74201933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

9 November 2019

title

Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

metastatic colon cancer

1 reference

1 reference

T. Painbeni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

E. Gamelin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

A. Cailleux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

A. Le Bouil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

M. Boisdron-Celle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

A. Daver

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

F. Larra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

P. Allain

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9470809

7 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9470809

7 December 2024

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

9 November 2019

November 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9470809

full work available at URL

7 December 2024

https://api.elsevier.com/content/article/PII:S0959804997003183?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

https://api.elsevier.com/content/article/PII:S0959804997003183?httpAccept=text/plain

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

European Journal of Cancer

7 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

9 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

9 November 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

2216-2220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

The value of CA 19-9 in gastric and colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Sialic acid content in mouse myeloma cells and derived B-cell hybridomas with different metastatic potentials

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Metastatic Potential Is Positively Correlated with Cell Surface Sialylation of Cultured Murine Tumor Cell Lines

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Serum-sialyltransferase activity in cancer patients

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Sialic acid as a marker for differentiation between benign and malignant intracranial tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Preoperative serum levels of CEA and CA 242 in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 January 2021

Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy

11

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

Sialic acid as a tumor marker

7 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary

7 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias

7 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

Sialic acid levels in various types of cancer

7 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

Serum sialic acid in normals and in cancer patients

7 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(97)00318-3

7 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809 AND SRC:MED&resulttype=core&format=json

9 November 2019

1 reference